6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-[1-(1,3-dioxolan-4-ylmethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-propylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;5-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-7-fluoro-2,3-dihydroisoindol-1-one;4-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-2-fluoro-N-methylbenzenesulfonamide;oxolane

C126H98F20N46O6S — CID 167706723

IUPAC6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-[1-(1,3-dioxolan-4-ylmethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-propylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;5-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-7-fluoro-2,3-dihydroisoindol-1-one;4-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-2-fluoro-N-methylbenzenesulfonamide;oxolane
SMILESC1CCOC1.CCCn1cc(-c2ccc3nnc(C(F)(F)c4cc5cn(C)nc5cc4F)n3n2)cn1.CNS(=O)(=O)c1ccc(-c2ccc3nnc(C(F)(F)c4cc5cn(C)nc5cc4F)n3n2)cc1F.Cn1cc(-c2ccc3nnc(C(F)(F)c4cc5cn(C)nc5cc4F)n3n2)cn1.Cn1cc2cc(C(F)(F)c3nnc4ccc(-c5cc(F)c6c(c5)CNC6=O)nn34)c(F)cc2n1.Cn1cc2cc(C(F)(F)c3nnc4ccc(-c5cnn(C6CC6)c5)nn34)c(F)cc2n1.Cn1cc2cc(C(F)(F)c3nnc4ccc(-c5cnn(CC6COCO6)c5)nn34)c(F)cc2n1
InChIInChI=1S/C22H13F4N7O.C21H15F4N7O2S.C21H17F3N8O2.C20H15F3N8.C20H17F3N8.C18H13F3N8.C4H8O/c1-32-9-12-5-13(14(23)7-17(12)30-32)22(25,26)21-29-28-18-3-2-16(31-33(18)21)10-4-11-8-27-20(34)19(11)15(24)6-10;1-26-35(33,34)18-5-3-11(8-15(18)23)16-4-6-19-27-28-20(32(19)30-16)21(24,25)13-7-12-10-31(2)29-17(12)9-14(13)22;1-30-7-12-4-15(16(22)5-18(12)28-30)21(23,24)20-27-26-19-3-2-17(29-32(19)20)13-6-25-31(8-13)9-14-10-33-11-34-14;1-29-9-11-6-14(15(21)7-17(11)27-29)20(22,23)19-26-25-18-5-4-16(28-31(18)19)12-8-24-30(10-12)13-2-3-13;1-3-6-30-11-13(9-24-30)16-4-5-18-25-26-19(31(18)28-16)20(22,23)14-7-12-10-29(2)27-17(12)8-15(14)21;1-27-9-11(7-22-27)14-3-4-16-23-24-17(29(16)26-14)18(20,21)12-5-10-8-28(2)25-15(10)6-13(12)19;1-2-4-5-3-1/h2-7,9H,8H2,1H3,(H,27,34);3-10,26H,1-2H3;2-8,14H,9-11H2,1H3;4-10,13H,2-3H2,1H3;4-5,7-11H,3,6H2,1-2H3;3-9H,1-2H3;1-4H2
InChIKeyZEXUIZXRIHIMTK-UHFFFAOYSA-N
MW2764.51 g/mol
LogP19.41
Rot. Bonds25

About 6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-[1-(1,3-dioxolan-4-ylmethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-propylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;5-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-7-fluoro-2,3-dihydroisoindol-1-one;4-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-2-fluoro-N-methylbenzenesulfonamide;oxolane

6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-[1-(1,3-dioxolan-4-ylmethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-propylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;5-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-7-fluoro-2,3-dihydroisoindol-1-one;4-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-2-fluoro-N-methylbenzenesulfonamide;oxolane (PubChem CID 167706723) has the molecular formula C126H98F20N46O6S and a molecular weight of 2764.51 g/mol. Its IUPAC name is 6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-[1-(1,3-dioxolan-4-ylmethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-propylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;5-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-7-fluoro-2,3-dihydroisoindol-1-one;4-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-2-fluoro-N-methylbenzenesulfonamide;oxolane.

Molecular Properties

Compound Name6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-[1-(1,3-dioxolan-4-ylmethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-propylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;5-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-7-fluoro-2,3-dihydroisoindol-1-one;4-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-2-fluoro-N-methylbenzenesulfonamide;oxolane
PubChem CID167706723
Molecular FormulaC126H98F20N46O6S
Molecular Weight2764.51 g/mol
Exact Mass2762.82
IUPAC Name6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-[1-(1,3-dioxolan-4-ylmethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-propylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;5-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-7-fluoro-2,3-dihydroisoindol-1-one;4-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-2-fluoro-N-methylbenzenesulfonamide;oxolane
SMILESC1CCOC1.CCCn1cc(-c2ccc3nnc(C(F)(F)c4cc5cn(C)nc5cc4F)n3n2)cn1.CNS(=O)(=O)c1ccc(-c2ccc3nnc(C(F)(F)c4cc5cn(C)nc5cc4F)n3n2)cc1F.Cn1cc(-c2ccc3nnc(C(F)(F)c4cc5cn(C)nc5cc4F)n3n2)cn1.Cn1cc2cc(C(F)(F)c3nnc4ccc(-c5cc(F)c6c(c5)CNC6=O)nn34)c(F)cc2n1.Cn1cc2cc(C(F)(F)c3nnc4ccc(-c5cnn(C6CC6)c5)nn34)c(F)cc2n1.Cn1cc2cc(C(F)(F)c3nnc4ccc(-c5cnn(CC6COCO6)c5)nn34)c(F)cc2n1
InChIInChI=1S/C22H13F4N7O.C21H15F4N7O2S.C21H17F3N8O2.C20H15F3N8.C20H17F3N8.C18H13F3N8.C4H8O/c1-32-9-12-5-13(14(23)7-17(12)30-32)22(25,26)21-29-28-18-3-2-16(31-33(18)21)10-4-11-8-27-20(34)19(11)15(24)6-10;1-26-35(33,34)18-5-3-11(8-15(18)23)16-4-6-19-27-28-20(32(19)30-16)21(24,25)13-7-12-10-31(2)29-17(12)9-14(13)22;1-30-7-12-4-15(16(22)5-18(12)28-30)21(23,24)20-27-26-19-3-2-17(29-32(19)20)13-6-25-31(8-13)9-14-10-33-11-34-14;1-29-9-11-6-14(15(21)7-17(11)27-29)20(22,23)19-26-25-18-5-4-16(28-31(18)19)12-8-24-30(10-12)13-2-3-13;1-3-6-30-11-13(9-24-30)16-4-5-18-25-26-19(31(18)28-16)20(22,23)14-7-12-10-29(2)27-17(12)8-15(14)21;1-27-9-11(7-22-27)14-3-4-16-23-24-17(29(16)26-14)18(20,21)12-5-10-8-28(2)25-15(10)6-13(12)19;1-2-4-5-3-1/h2-7,9H,8H2,1H3,(H,27,34);3-10,26H,1-2H3;2-8,14H,9-11H2,1H3;4-10,13H,2-3H2,1H3;4-5,7-11H,3,6H2,1-2H3;3-9H,1-2H3;1-4H2
InChIKeyZEXUIZXRIHIMTK-UHFFFAOYSA-N
XLogP19.41
TPSA539.64 Ų
H-Bond Donors2
H-Bond Acceptors50
Rotatable Bonds25
Heavy Atoms199
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002764.51
LogP ≤ 519.41
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1050

Analyze 6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-[1-(1,3-dioxolan-4-ylmethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-propylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;5-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-7-fluoro-2,3-dihydroisoindol-1-one;4-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-2-fluoro-N-methylbenzenesulfonamide;oxolane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-[1-(1,3-dioxolan-4-ylmethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-propylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;5-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-7-fluoro-2,3-dihydroisoindol-1-one;4-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-2-fluoro-N-methylbenzenesulfonamide;oxolane?
The IUPAC name of 6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-[1-(1,3-dioxolan-4-ylmethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-propylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;5-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-7-fluoro-2,3-dihydroisoindol-1-one;4-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-2-fluoro-N-methylbenzenesulfonamide;oxolane (CID 167706723) is 6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-[1-(1,3-dioxolan-4-ylmethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-propylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;5-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-7-fluoro-2,3-dihydroisoindol-1-one;4-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-2-fluoro-N-methylbenzenesulfonamide;oxolane.
What is the SMILES notation for 6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-[1-(1,3-dioxolan-4-ylmethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-propylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;5-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-7-fluoro-2,3-dihydroisoindol-1-one;4-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-2-fluoro-N-methylbenzenesulfonamide;oxolane?
The canonical SMILES for 6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-[1-(1,3-dioxolan-4-ylmethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-propylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;5-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-7-fluoro-2,3-dihydroisoindol-1-one;4-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-2-fluoro-N-methylbenzenesulfonamide;oxolane is C1CCOC1.CCCn1cc(-c2ccc3nnc(C(F)(F)c4cc5cn(C)nc5cc4F)n3n2)cn1.CNS(=O)(=O)c1ccc(-c2ccc3nnc(C(F)(F)c4cc5cn(C)nc5cc4F)n3n2)cc1F.Cn1cc(-c2ccc3nnc(C(F)(F)c4cc5cn(C)nc5cc4F)n3n2)cn1.Cn1cc2cc(C(F)(F)c3nnc4ccc(-c5cc(F)c6c(c5)CNC6=O)nn34)c(F)cc2n1.Cn1cc2cc(C(F)(F)c3nnc4ccc(-c5cnn(C6CC6)c5)nn34)c(F)cc2n1.Cn1cc2cc(C(F)(F)c3nnc4ccc(-c5cnn(CC6COCO6)c5)nn34)c(F)cc2n1.
What is the InChIKey of 6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-[1-(1,3-dioxolan-4-ylmethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-propylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;5-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-7-fluoro-2,3-dihydroisoindol-1-one;4-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-2-fluoro-N-methylbenzenesulfonamide;oxolane?
The InChIKey is ZEXUIZXRIHIMTK-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H13F4N7O.C21H15F4N7O2S.C21H17F3N8O2.C20H15F3N8.C20H17F3N8.C18H13F3N8.C4H8O/c1-32-9-12-5-13(14(23)7-17(12)30-32)22(25,26)21-29-28-18-3-2-16(31-33(18)21)10-4-11-8-27-20(34)19(11)15(24)6-10;1-26-35(33,34)18-5-3-11(8-15(18)23)16-4-6-19-27-28-20(32(19)30-16)21(24,25)13-7-12-10-31(2)29-17(12)9-14(13)22;1-30-7-12-4-15(16(22)5-18(12)28-30)21(23,24)20-27-26-19-3-2-17(29-32(19)20)13-6-25-31(8-13)9-14-10-33-11-34-14;1-29-9-11-6-14(15(21)7-17(11)27-29)20(22,23)19-26-25-18-5-4-16(28-31(18)19)12-8-24-30(10-12)13-2-3-13;1-3-6-30-11-13(9-24-30)16-4-5-18-25-26-19(31(18)28-16)20(22,23)14-7-12-10-29(2)27-17(12)8-15(14)21;1-27-9-11(7-22-27)14-3-4-16-23-24-17(29(16)26-14)18(20,21)12-5-10-8-28(2)25-15(10)6-13(12)19;1-2-4-5-3-1/h2-7,9H,8H2,1H3,(H,27,34);3-10,26H,1-2H3;2-8,14H,9-11H2,1H3;4-10,13H,2-3H2,1H3;4-5,7-11H,3,6H2,1-2H3;3-9H,1-2H3;1-4H2.
What are the key properties of 6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-[1-(1,3-dioxolan-4-ylmethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-propylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;5-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-7-fluoro-2,3-dihydroisoindol-1-one;4-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-2-fluoro-N-methylbenzenesulfonamide;oxolane?
6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-[1-(1,3-dioxolan-4-ylmethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-propylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;5-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-7-fluoro-2,3-dihydroisoindol-1-one;4-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-2-fluoro-N-methylbenzenesulfonamide;oxolane has a molecular weight of 2764.51 g/mol, XLogP of 19.41, 25 rotatable bonds, 2 hydrogen bond donors, and 50 hydrogen bond acceptors.
Where does this data come from?
All data for 6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-[1-(1,3-dioxolan-4-ylmethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-6-(1-propylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine;5-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-7-fluoro-2,3-dihydroisoindol-1-one;4-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-2-fluoro-N-methylbenzenesulfonamide;oxolane is sourced from PubChem (CID 167706723), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).